{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:42:32Z","timestamp":1793763752837,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.mayocp.2019.05.011","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T08:08:15Z","timestamp":1577952495000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Surveillance in Patients With Diffuse Large B Cell Lymphoma"],"prefix":"10.1016","volume":"95","author":[{"given":"Avyakta","family":"Kallam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5259-2966","authenticated-orcid":false,"given":"Jayanth","family":"Adusumalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 5","key":"10.1016\/j.mayocp.2019.05.011_bib2","doi-asserted-by":"crossref","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mayocp.2019.05.011_bib3","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.14694\/EdBook_AM.2014.34.e388","article-title":"Surveillance imaging for lymphoma: Pros and cons","author":"Lynch","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"34","key":"10.1016\/j.mayocp.2019.05.011_bib4","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2015.63.5946","article-title":"To surveil or not to surveil","volume":"33","author":"Armitage","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.05.011_bib5","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-12-3837","article-title":"Age-adjusted international prognostic index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma","volume":"102","author":"Hamlin","year":"2003","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.mayocp.2019.05.011_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A\u00a0predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocp.2019.05.011_bib7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1200\/JCO.2013.51.5866","article-title":"Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"32","author":"Maurer","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.mayocp.2019.05.011_bib8","first-page":"58","article-title":"Relapse characteristics and the role of surveillance computed tomography in aggressive non-Hodgkin lymphoma","volume":"102","author":"Kang","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.mayocp.2019.05.011_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/blood-2016-08-685073","article-title":"Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma","volume":"129","author":"Cohen","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.011_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clml.2015.12.006","article-title":"Role of surveillance imaging in patients with peripheral T-cell lymphoma","volume":"16","author":"Tang","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1016\/j.mayocp.2019.05.011_bib11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00277-014-2040-1","article-title":"Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy","volume":"93","author":"Cheah","year":"2014","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.mayocp.2019.05.011_bib12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.clml.2016.08.018","article-title":"Impact of routine surveillance imaging on outcomes of patients with diffuse large B-cell lymphoma after autologous hematopoietic cell transplantation","volume":"16","author":"Epperla","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"31","key":"10.1016\/j.mayocp.2019.05.011_bib13","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","article-title":"Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma","volume":"32","author":"Thompson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.05.011_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/annonc\/mdl049","article-title":"Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population","volume":"17","author":"Liedtke","year":"2006","journal-title":"Ann Oncol"},{"issue":"34","key":"10.1016\/j.mayocp.2019.05.011_bib15","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1200\/JCO.2015.62.0229","article-title":"Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish\u2013Swedish population-based study","volume":"33","author":"El-Galaly","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.05.011_bib16","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1200\/JCO.2008.16.1513","article-title":"Role of [18F] fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma","volume":"27","author":"Zinzani","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.mayocp.2019.05.011_bib17","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/annonc\/mdq215","article-title":"Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors","volume":"21","author":"Thompson","year":"2010","journal-title":"Ann Oncol"},{"issue":"22","key":"10.1016\/j.mayocp.2019.05.011_bib18","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/archinternmed.2009.427","article-title":"Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer","volume":"169","author":"Smith-Bindman","year":"2009","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.05.011_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ijc.29433","article-title":"Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: a nationwide population-based study","volume":"137","author":"Chien","year":"2015","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.mayocp.2019.05.011_bib20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2014.58.5729","article-title":"Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission","volume":"33","author":"Huntington","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.05.011_bib21","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.clml.2017.10.003","article-title":"Are we choosing wisely in lymphoma? Excessive use of surveillance CT imaging in patients with diffuse large B-cell lymphoma (DLBCL) in long-term remission","volume":"18","author":"Cheung","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"17","key":"10.1016\/j.mayocp.2019.05.011_bib22","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.2012.476","article-title":"Choosing wisely: helping physicians and patients make smart decisions about their care","volume":"307","author":"Cassel","year":"2012","journal-title":"JAMA"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619304690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619304690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:15Z","timestamp":1758418275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619304690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0025619619304690"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.05.011","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance in Patients With Diffuse Large B Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}